In one of these, Sun et al. reported markedly increased CPA4 levels in the tumor tissues and serum samples of patients with pancreatic cancer and associated this marker with tumor progression and poor prognosis [16]. This evidence concerns the gene CPA4 and pancreatic neoplasm.